市场和渠道信心双双回暖 业内首只浮费医疗QDII提前结募

Core Viewpoint - The public fund industry in China is undergoing a significant fee reform, highlighted by the successful early fundraising of the Oriental Red Medical Innovation Mixed Fund (QDII), which is the first floating management fee fund in the medical sector, reflecting investor confidence in the market and the asset management capabilities of Oriental Red [1][2]. Group 1: Fund Performance and Management - The Oriental Red Medical Innovation Mixed Fund (QDII) has gained recognition for its management capabilities, with the fund manager's income linked to investor returns, marking a shift towards prioritizing investor benefits over mere scale [2][4]. - Fund managers Jiang Qi and Gao Yi have extensive backgrounds in the medical and financial sectors, contributing to the fund's strong performance and investor trust [2][3]. - The Oriental Red Medical Upgrade Stock Initiation Fund, managed by Jiang Qi, has shown impressive results, with a net value growth rate of 102.43% over the past year [3]. Group 2: Industry Impact and Future Outlook - The introduction of floating fee structures is expected to have a profound impact across the industry, incentivizing fund managers to enhance their research and risk management capabilities, thereby fostering a culture of long-term value investment [4][5]. - The successful fundraising of the Oriental Red Medical Innovation Mixed Fund (QDII) indicates strong investor confidence in the long-term prospects of the medical industry and the asset management capabilities of Oriental Red [5]. - The collaboration between Oriental Red Asset Management and partners like Pudong Development Bank and Oriental Securities aims to provide long-term investment options and enhance investor engagement, contributing to the high-quality development of the asset management industry [5].